Fenofibric acid (TriLipix)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fenofibric acid (TriLipix), covering 2024-12-18 to 2024-12-18. Get the full timeline:
Most recent: Clinical Trial Update: AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis [Phase 3]